The rise in COVID-19 cases during the summer hints at a potential increase in infections this winter. Health experts anticipate that colder months could lead to a spike in cases.
Many states have connected pharmacists’ ability to administer COVID-19 vaccines with the recommendations set by the Advisory Committee on Immunization Practices (ACIP).
Earlier this year, efforts to prepare updated COVID-19 vaccines for the fall seemed to be on schedule. The Food and Drug Administration’s advisory committee played a key role by selecting current strains to target with new vaccines. The agency endorsed these recommendations and relayed them to vaccine manufacturers, signaling action in preparing for upcoming health challenges.
Orland Park Village Board Approves $275 Million Northwestern Medicine Expansion 
Study Finds Increased Cancer Risk Among Flight Attendants and Pilots Due to Radiation Exposure 
Young and Nonsmoking, Yet Facing Lung Cancer 
Factors Influencing Prescription Drug Price Changes 
U.S. Faces Rising Measles Outbreaks Amid Vaccine Concerns 
Senate Proposal Aims to Extend Nutrition Assistance for Low-Income Mothers